MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA)
$3.87
N/A ( 0% ) 76.9K
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Market Data
Open
$3.87
Previous close
$3.87
Volume
76.9K
Market cap
$81.78M
Day range
$3.65 - $3.90
52 week range
$0.82 - $5.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Feb 14, 2024 |
8-k | 8K-related | 15 | Jan 30, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
8-k | 8K-related | 13 | Jan 18, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |